论文部分内容阅读
目的:对腹腔镜下子宫动脉阻断联合肌瘤剔除术治疗子宫肌瘤临床治疗效果进行分析。方法:选取2013年2月至2013年8月在我院接受子宫动脉阻断联合肌瘤剔除术并要求保留子宫的子宫肌瘤患者50例,将患者分为两组,其中观察组20例患者实施子宫动脉阻断联合肌瘤剔除术中采取腹腔镜配手术,对照组患者30例,接受腹腔镜下子宫肌瘤剔除术。结果:观察组患者术中出血量为(86.52±17.22)ml,对照组患者术中出血量为(164.21±27.54)ml,两组患者出血量差异显著,(P<0.05)有统计学意义;观察组患者术后住院天数为(7.2±2.1)d,对照组患者住院天数为(8.8±3.2)d,两组患者住院天数差异显著,(P<0.05)有统计学意义。结论:腹腔镜下子宫动脉阻断联合肌瘤剔除术能够满足不同子宫肌瘤患者对手术的要求,并能够取得较为满意的治疗效果,腹腔镜下子宫动脉阻断联合肌瘤剔除术具有术中出血量少、手术时间短的特点,并且能够有效降低术后复发率,手术过程中术野较为清晰,对坏死组织有显著的减少作用,并且具有术后并发症少的优点,在临床子宫肌瘤治疗中值得推广。
Objective: To analyze the clinical effect of laparoscopic uterine artery occlusion combined with myomectomy in the treatment of uterine fibroids. Methods: From February 2013 to August 2013 in our hospital to accept uterine artery occlusion myomectomy and asked to retain uterine fibroids in 50 patients, the patients were divided into two groups, of which 20 patients in the observation group The implementation of uterine artery occlusion myomectomy with laparoscopic surgery, the control group of 30 patients undergoing laparoscopic myomectomy. Results: The intraoperative blood loss in the observation group was (86.52 ± 17.22) ml, while that in the control group was (164.21 ± 27.54) ml. There was significant difference between the two groups in the amount of bleeding (P <0.05) The postoperative hospital stay was (7.2 ± 2.1) days in the observation group and (8.8 ± 3.2) days in the control group. There was significant difference between the two groups in hospitalization days (P <0.05). Conclusion: Laparoscopic uterine artery occlusion combined with myomectomy can meet the requirements of patients with different uterine fibroids and can achieve satisfactory results. Laparoscopic uterine artery occlusion combined with myomectomy has the advantages of intraoperative Less blood loss, shorter operative time, and can effectively reduce the recurrence rate, the surgical field during surgery is relatively clear, a significant reduction in necrotic tissue, and has the advantage of fewer postoperative complications in the clinical uterine muscle Tumor treatment worth promoting.